Chelsea M. Rutherford

Chelsea M. Rutherford focuses her practice on corporate, transactional and regulatory matters affecting a wide range of clients in the health care and life sciences industries. Read Chelsea M. Rutherford's full bio.
New OIG Reports Peg Billing Trends and Prescribing Hotspots as Harbingers of Part D Fraud
By Chelsea M. Rutherford on Jun 30, 2015
Posted In Pharmaceuticals
On Tuesday, June 23, the U.S. Department of Health & Human Services Office of Inspector General (OIG) released two reports that hone in on data patterns showing potential fraud and abuse in the Medicare Part D program. These reports were released less than a week after a coordinated national Medicare fraud takedown that included a...
Continue Reading
Recent OIG Report Spotlights Millions in Overpayments Caused by Physician Place-of-Service Coding Errors
By Chelsea M. Rutherford and Tony Maida on Jun 18, 2015
Posted In Uncategorized
On May 6, 2015, the Office of Inspector General (OIG) for the U.S. Department of Health & Human Services (HHS) released a report on overpayments attributed to incorrect physician place-of-service coding. The report determined that Medicare potentially overpaid physicians approximately $33.4 million for incorrectly coded services that were provided from January 2010 through September 2012....
Continue Reading